Table 3.
Participant intake information on entry into the investigation and completion of testing conditions
| Participant | Demographic Data |
Diagnosis | Months Post- Onset |
Functional Oral Intake Scale score* |
Testing completed |
|---|---|---|---|---|---|
| S1 | 80 y; male | Brainstem CVA |
18 | 2, Mod/Sev | All |
| S2 | 56 y; male | Brainstem CVA |
44 | 1, Severe | All |
| S3 | 51 y; male | Brainstem CVA |
12 | 1, Severe | Frequency & Pressure |
| S4 | 62 y; male | Brainstem and cerebellar CVA |
10 | 3, Moderate | All |
| S5 | 70 y; female | Brainstem CVA |
42 | 2, Mod/Sev | Frequency, Pressure, Mode |
| S6 | 15 y; female | Brainstem CVA |
53 | 1, Severe | Frequency |
| S7 | 59 y; male | Brainstem CVA |
36 | 2, Mod/Sev | Frequency, Pressure, Mode |
| S8 | 58 y, male | Brainstem CVA |
31 | 1, Severe | Frequency, Pressure, Mode |
| S9 | 74 y; male | Brainstem CVA |
32 | 2, Mod/Sev | All |
| S10 | 67 y; male | Head/ neck CA |
17 | 1, Severe | All |
| S11 | 76 y; male | Head/ neck CA |
160 | 2, Mod/Sev | All |
| S12 | 50 y; male | Head/ neck CA |
36 | 1, Severe | All |
| S13 | 69 y; male | Head/ neck CA |
131 | 1, Severe | All |